Heterogeneity of triple-negative breast cancer is well known at clinical, histopathological,
and molecular levels. Genomic instability and greater mutation rates, which may result in the …

Abstract Triple-Negative Breast Cancer (TNBC) presents a significant challenge in oncology
due to its aggressive behavior and limited therapeutic options. This review explores the …

Enterobacter cloacae is mainly responsible for sepsis, urethritis, and respiratory tract
infections. These bacteria may affect the transcription of the host and particularly their …

Immunotherapy is revam** the therapeutic strategies for TNBC owing to its higher
mutational burden and tumour-associated antigens. One of the most intriguing …

Immunotherapies are a promising treatment option especially for the management of TNBC
owing to its higher levels of tumour-associated antigens together with higher mutational …

Immunotherapy is emerging as a potential therapeutic strategy for triple negative breast
cancer (TNBC) owing to the immunogenic landscape of its tumor microenvironment …

Breast cancer (BC) continues to be the malignancy with the highest diagnosis rate
worldwide. Between 15% and 30% of BC patients show overexpressed human epidermal …

Triple negative breast cancer (TNBC) is a very invasive subtype of breast cancer (BCa), this
is accounted for 15–20% of all BCa cases. TNBC patients have very limited therapy option …

The understanding of the molecular basis of complex diseases like hepatocellular
carcinoma (HCC) needs large datasets of multiple genes and proteins involved in different …

Introduction: Targeting tumor microenvironment is beneficial and present an ideal setting for
the development of futuristic immunotherapy. Here, we make use of Nuclear prelamin A …